IP Library Granted Patent US 10,792,394
Granted Patent B2
US 10,792,394 · App. 15/606,924 · Granted Oct 6, 2020

Methods for localized modification of tissue products

Inventors: Ming F. Pomerleau (Califon, NJ); Hua Wan (Princeton, NJ); Hui Xu (Plainsboro, NJ); Dennis Y. Lee (Scotch Plains, NJ)
Assignee: LIFECELL CORPORATION
A61L27/3687A61L27/362A61L27/3625A61L27/3629A61L27/3691A61K38/39A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,792,394
App. No.
15/606,924
Granted
Oct 6, 2020
Kind
B2
Abstract

Methods for treating tissue matrices and tissue matrices produced according to the methods are provided. The methods can include treating select portions of a tissue matrix with a fluid containing at least one agent to produce a tissue matrix with variable mechanical and/or biological properties.

Claims (36)

1. A method for modifying a tissue product, comprising:

selecting a collagen-containing tissue product;

providing a hydrophilic material having at least one strut having a shape corresponding to a desired pattern;

applying to the hydrophilic material a fluid containing at least one agent capable of passing through the hydrophilic material to a top side of the hydrophilic material and modifying the collagen-containing tissue product; and

contacting the collagen-containing tissue product with the at least one strut at the top side of the hydrophilic material to bring select regions of the collagen-containing tissue product into contact with the top side of the hydrophilic material and the fluid.

2. The method of claim 1 , wherein the tissue product is an acellular tissue matrix.

3. The method of claim 2 , wherein the tissue product comprises a dermal tissue matrix.

4. The method claim 2 , wherein the tissue product is derived from a tissue selected from fascia adipose, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, muscle, and intestinal tissue.

5. The method of claim 1 , wherein the hydrophilic material is placed on top of the collagen-containing tissue product.

6. The method of claim 5 , further comprising applying a vertical force on the hydrophilic material.

7. The method of claim 1 , wherein the collagen-containing tissue product is placed on top of the hydrophilic material.

8. The method of claim 7 , further comprising applying a vertical force on the collagen-containing tissue product.

9. The method of claim 1 , wherein the hydrophilic material forms at least one of a serpentine pattern, a web-like pattern, a circular pattern, a grid pattern, an elongated pattern, an elongated pattern with extensions, and a linear pattern.

10. The method of claim 1 , wherein the at least one agent comprises at least one of glutaraldehyde and 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC).

11. The method of claim 1 , wherein the at least one agent comprises a cross-linking agent.

12. The method of claim 1 , wherein at least one agent comprises an enzyme.

13. The method of claim 12 , wherein the enzyme is selected from at least one of bromelain, papain, ficin, actinidin, alcalase, trypsin, dispase or combinations thereof.

14. The method of claim 1 , wherein the at least one agent includes at least one of an antimicrobial, an anti-inflammatory, or a growth factor.

15. A method for modifying a tissue product, comprising:

selecting a collagen-containing tissue product;

providing a material having at least one strut having a shape corresponding to a desired pattern;

applying to the material a fluid containing at least one agent capable of passing through the material to a top side of the material and modifying the collagen-containing tissue product; and

contacting the collagen-containing tissue product with the at least one strut at the top side of the material to bring select regions of the collagen-containing tissue product into contact with the top side of the material and the fluid.

16. The method of claim 15 , wherein the tissue product is an acellular tissue matrix.

17. The method of claim 16 , wherein the tissue product comprises a dermal tissue matrix.

18. The method claim 16 , wherein the tissue product is derived from a tissue selected from fascia adipose, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, muscle, and intestinal tissue.

19. The method of claim 15 , wherein the material is placed on top of the collagen-containing tissue product.

20. The method of claim 19 , further comprising applying a vertical force on the material.

21. The method of claim 15 , wherein the collagen-containing tissue product is placed on top of the material.

22. The method of claim 21 , further comprising applying a vertical force on the collagen-containing tissue product.

23. The method of claim 15 , wherein the material forms at least one of a serpentine pattern, a web-like pattern, a circular pattern, a grid pattern, an elongated pattern, an elongated pattern with extensions, and a linear pattern.

24. The method of claim 15 , wherein the at least one agent comprises at least one of glutaraldehyde and 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC).

25. The method of claim 15 , wherein the at least one agent comprises a cross-linking agent.

26. The method of claim 15 , wherein at least one agent comprises an enzyme.

27. The method of claim 26 , wherein the enzyme is selected from at least one of bromelain, papain, ficin, actinidin, alcalase, trypsin, dispase or combinations thereof.

28. The method of claim 15 , wherein the at least one agent includes at least one of an antimicrobial, an anti-inflammatory, or a growth factor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: FANG, MING; WAN, HUA; XU, HUI; LEE, DENNIS Y.
To: LIFECELL CORPORATION
Reel/Frame 043017/0239 →
Continuity (2)
Provisional Application 62345346 · Jun 3, 2016
Related Publication 20170348460A1 · Dec 7, 2017